DaShenLin Pharmaceutical Group Co., Ltd. (SHA: 603233)

DaShenLin Pharmaceutical Group Market Cap

DaShenLin Pharmaceutical Group has a market cap or net worth of 17.42 billion as of October 11, 2024. Its market cap has decreased by -40.93% in one year.

• Market Cap: 17.42B
• Enterprise Value: 20.79B
• Revenue: 25.88B
• Ranking: n/a
• PE Ratio: 19.12
• Stock Price: 15.30

Market Cap Chart

Since July 31, 2017, DaShenLin Pharmaceutical Group's market cap has increased from 14.24B to 17.42B, an increase of 22.36%. That is a compound annual growth rate of 2.84%.

Market Cap History

Date	Market Cap	% Change
Oct 10, 2024	17.42B	-38.56%
Dec 29, 2023	28.36B	-24.55%
Dec 30, 2022	37.59B	12.85%
Dec 31, 2021	33.31B	-35.46%
Dec 31, 2020	51.60B	89.92%
Dec 31, 2019	27.17B	70.41%